Gene · 7994
Papers1,720
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,720
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Retinal determination network reactivation drives chemoresistance and blocks myeloid differentiation in acute myeloid leukemia. | Cell Rep | 2026 | 41575857 | PubTator, text mining | PubMed |
| Histone and non-histone (de)acetylation impact on the blood-brain barrier. | Fluids Barriers CNS | 2026 | 41566325 | PubTator, text mining | PubMed |
| Seamless and Highly Efficient Site-directed Mutagenesis for Protein, RNA, and Plasmid Engineering. | Curr Protoc | 2026 | 41543491 | PubTator, text mining | PubMed |
| Bone Marrow Failure as an Underrecognized Feature of KAT6A Syndrome. | Pediatr Blood Cancer | 2026 | 41449995 | PubTator, text mining | PubMed |
| Diagnostic value of genetic testing, with focus on CACNA1A, in children with episodic neurologic disorders: a single-centre retrospective study. | Eur J Paediatr Neurol | 2026 | 41370964 | PubTator, text mining | PubMed |
| KAT6A regulates osteoclast differentiation and bone resorption through TET1-mediated TRPV4 expression. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 41175189 | PubTator, text mining | PubMed |
| RESTRICT-seq enables time-gated CRISPR screens and uncovers novel epigenetic dependencies of SCC resistance. | bioRxiv | 2026 | 41000660 | PubTator, text mining | PubMed |
| Histone acetyltransferase KAT6A contributes to colon cancer malignant progression by inhibiting ferroptosis. | BMC Cancer | 2025 | 41454337 | PubTator, text mining | PubMed |
| Early onset Arboleda-Tham syndrome due to KAT6A variants: Case report. | Front Genet | 2025 | 41431654 | PubTator, text mining | PubMed |
| Lysine Acetyltransferase 6 in Health and Disease. | MedComm (2020) | 2025 | 41357671 | PubTator, text mining | PubMed |
| KAT6A acetyltransferase accelerates colorectal cancer progression through upregulating BRD1 protein expression via acetylation modification. | Cancer Cell Int | 2025 | 41254720 | PubTator, text mining | PubMed |
| Genomic Investigations of Spoken and Written Language Abilities: A Guide to Advances in Approaches, Technologies, and Discovery. | J Speech Lang Hear Res | 2025 | 41159814 | PubTator, text mining | PubMed |
| Breaking Barriers in Breast Cancer: Multi-Targeted Therapeutic Insights. | Mini Rev Med Chem | 2025 | 41088941 | PubTator, text mining | PubMed |
| Mammalian H4K16ac regulates the spatiotemporal order of genome replication rather than gene expression. | Nucleic Acids Res | 2025 | 40985775 | PubTator, text mining | PubMed |
| Acute Myeloid Leukemia With KAT6A Deletion in a 7-Week-Old. | Pediatr Blood Cancer | 2025 | 40985528 | PubTator, text mining | PubMed |
| Correlation between KAT6A and PD-L1 expression and role of KAT6A in colorectal cancer. | World J Gastrointest Oncol | 2025 | 40977654 | PubTator, text mining | PubMed |
| IV Immunoglobulin Is Associated With Epigenetic, Ribosomal, and Immune Changes in Pediatric Acute-Onset Neuropsychiatric Syndrome. | Neurol Neuroimmunol Neuroinflamm | 2025 | 40953324 | PubTator, text mining | PubMed |
| The MLLT3 YEATS domain is a dual reader of histone marks (H3K9/18/27ac/cr) and ncRNA (7SK), linking epigenetic and RNA signaling to regulate hematopoiesis. | bioRxiv | 2025 | 40950097 | PubTator, text mining | PubMed |
| KMT2A-rearranged leukemia: from mechanism to drug development. | Exp Hematol | 2025 | 40921261 | PubTator, text mining | PubMed |
| Histone H3K27 acetylation mediated by KAT8 maintains antiviral trained immunity in shrimp induced by inactivated white spot syndrome virus. | Commun Biol | 2025 | 40885857 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7994/papers?page=3